Publications

2014
Malka Gorfine, Li Hsu, David M Zucker, and Giovanni Parmigiani. 2014. “Calibrated predictions for multivariate competing risks models.” Lifetime data analysis, 20, 2, Pp. 234–251.
Danielle Braun, Malka Gorfine, Hormuzd A Katki, Argyrios Ziogas, Hoda Anton-Culver, and Giovanni Parmigiani. 2014. “Extending mendelian risk prediction models to handle misreported family history”.
Danielle Braun, Malka Gorfine, and Giovanni Parmigiani. 2014. “Misreported family histories and underestimation of risk.” Journal of Clinical Oncology, 32, 32, Pp. 3682–3683.
Emanuele Mazzola, Jonathan Chipman, Su-Chun Cheng, and Giovanni Parmigiani. 2014. “Recent BRCAPRO upgrades significantly improve calibration.” Cancer Epidemiology and Prevention Biomarkers, 23, 8, Pp. 1689–1695.
Swati Biswas, Banu Arun, and Giovanni Parmigiani. 2014. “Reclassification of predictions for uncovering subgroup specific improvement.” Statistics in medicine, 33, 11, Pp. 1914–1927.
2013
Malka Gorfine*, Li Hsu*, and Giovanni Parmigiani. 2013. “Frailty models for familial risk with application to breast cancer.” Journal of the American Statistical Association, 108, 504, Pp. 1205–1215.
Emanuele Mazzola, Su-Chun Cheng, and Giovanni Parmigiani. 2013. “The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers.” Breast cancer research and treatment, 137, 1, Pp. 315–318.
Jonathan Chipman, Brian Drohan, Amanda Blackford, Giovanni Parmigiani, Kevin Hughes, and Phil Bosinoff. 2013. “Providing access to risk prediction tools via the HL7 XML-formatted risk web service.” Breast cancer research and treatment, 140, 1, Pp. 187–193.
Swati Biswas, Philamer Atienza, Jonathan Chipman, Kevin Hughes, Angelica Gutierrez M Barrera, Christopher I Amos, Banu Arun, and Giovanni Parmigiani. 2013. “Simplifying clinical use of the genetic risk prediction model BRCAPRO.” Breast cancer research and treatment, 139, 2, Pp. 571–579.
2012
Swati Biswas, Neelam Tankhiwale, Amanda Blackford, Angelica Gutierrez M Barrera, Kaylene Ready, Karen Lu, Christopher I Amos, Giovanni Parmigiani, and Banu Arun. 2012. “Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO.” Breast cancer research and treatment, 133, 1, Pp. 347–355.
Suzanne B Coopey, Emanuele Mazzola, Julliette M Buckley, John Sharko, Ahmet K Belli, Elizabeth MH Kim, Fernanda Polubriaginof, Giovanni Parmigiani, Judy E Garber, Barbara L Smith, and others. 2012. “The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.” Breast cancer research and treatment, 136, 3, Pp. 627–633.
2010
M.F. Ochs, A. Blackford, and G. Parmigiani. 2010. Biomedical informatics in cancer research. Springer Verlag.
Wenyi Wang, Kristin B Niendorf, Devanshi Patel, Amanda Blackford, Fabio Marroni, Arthur J Sober, Giovanni Parmigiani, and Hensin Tsao. 2010. “Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO.” Cancer research, 70, 2, Pp. 552–559.
Amanda Blackford and Giovanni Parmigiani. 2010. “Familial Cancer Risk Assessment Using BayesMendel.” In Biomedical Informatics for Cancer Research, Pp. 301–314. Springer.
2009
Li Wang, Kieran A Brune, Kala Visvanathan, Daniel Laheru, Joseph Herman, Christoper Wolfgang, Richard Schulick, John L Cameron, Michael Goggins, Ralph H Hruban, and others. 2009. “Elevated cancer mortality in the relatives of patients with pancreatic cancer.” Cancer Epidemiology and Prevention Biomarkers, 18, 11, Pp. 2829–2834.
Sining Chen, Amanda L Blackford, and Giovanni Parmigiani. 2009. “Tailoring BRCAPRO to Asian-Americans.” Journal of Clinical Oncology, 27, 4, Pp. 642–643.
Li Wang, Kieran A Brune, Kala Visvanathan, Daniel Laheru, Joseph Herman, Christoper Wolfgang, Richard Schulick, John L Cameron, Michael Goggins, Ralph H Hruban, and others. 2009. “Elevated cancer mortality in the relatives of patients with pancreatic cancer.” Cancer Epidemiology and Prevention Biomarkers, Pp. 1055–9965.
2008
Yu Chuan Tai, Sining Chen, Giovanni Parmigiani, and Alison P Klein. 2008. “Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.” Breast Cancer Research, 10, 2, Pp. 401.
Hormuzd A Katki, Amanda Blackford, Sining Chen, and Giovanni Parmigiani. 2008. “Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO.” Statistics in medicine, 27, 22, Pp. 4532–4548.
2007
Yu Chuan Tai, Susan Domchek, Giovanni Parmigiani, and Sining Chen. 2007. “Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.” Journal of the National Cancer Institute, 99, 23, Pp. 1811–1814.

Pages